J Kevin Buchi insider trades
Open-market stock purchases and sales by J Kevin Buchi, Director at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 17, 2006.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +128%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 17, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | — |
| Sep 11, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | $295K |
| Sep 11, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Aug 11, 2026 | AMRX Amneal Pharmaceuticals, Inc | Sold (not open market) | $2.9M |
| Jun 29, 2026 | BNTC Benitec Biopharma Inc | Sold (not open market) | — |
| May 7, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| May 6, 2026 | AMRX Amneal Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 1, 2025 | BNTC Benitec Biopharma Inc | Bought (not open market) | — |
Companies traded
- AMRX Amneal Pharmaceuticals, Inc: other filings, last Sep 17, 2026
- BNTC Benitec Biopharma Inc: 1 buy, last Jun 29, 2026
- AMPE Ampio Pharmaceuticals, Inc: 5 buys, last Jun 9, 2023
- DRNA Dicerna Pharmaceuticals Inc: other filings, last Dec 28, 2021
- ZIOP Ziopharm Oncology Inc: other filings, last Mar 4, 2021
- BSTC Biospecifics Technologies Corp: other filings, last Oct 23, 2019
- IPXL Impax Laboratories, LLC: other filings, last May 4, 2018
- ALXA Alexza Pharmaceuticals Inc: other filings, last Jun 21, 2016
- STML Stemline Therapeutics Inc: 1 buy, last Jun 23, 2015
- EPRS EPIRUS Biopharmaceuticals, Inc: other filings, last Jun 5, 2015
- TLOG Tetralogic Pharmaceuticals Corp: 7 buys, last Mar 26, 2015
- CEPH Cephalon Inc: 2 sales, last Oct 14, 2011